11-108249096-TG-CT
Variant summary
The NM_000051.4(ATM):c.1229_1230delTGinsCT (p.Val410Ala) variant causes a missense change. The gene ATM is a tumor suppressor gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a known oncogene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a cancer driver gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V410A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127332); p.V410L: Uncertain_significance (ClinVar VariationId 3967210, 1 star); p.V410M: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 216190); p.V410= (synonymous): Likely_benign (ClinVar VariationId 453357, 2 stars); p.V410= (synonymous): Likely_benign (ClinVar VariationId 1155205, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Publications
- ATM-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Natera, Ambry Genetics
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, G2P, Orphanet, Natera, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 2 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 3 pathogenic, 3 benign (OR vs. background: 5.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| B2Does not fit gene mode of action | Activating variant in tumor suppressor gene + same AA change classified germline Benign/Likely Benign — supporting benign evidence (B2, no cancer-type context); Activating variant in tumor suppressor gene + same AA change classified germline Benign/Likely Benign — supporting benign evidence (B2, no cancer-type context) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATM | MANE Select | c.1229_1230delTGinsCT p.Val410Ala | missense | N/A | Prot: NP_000042.3 | |
ATM | c.1229_1230delTGinsCT p.Val410Ala | missense | N/A | Prot: NP_001338763.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATM | MANE Select | c.1229_1230delTGinsCT p.Val410Ala | missense | N/A | Prot: ENSP00000501606.1 UniProt: | |
ATM | TSL:1 | c.1229_1230delTGinsCT p.Val410Ala | missense | N/A | Prot: ENSP00000388058.2 UniProt: | |
ATM | TSL:1 | c.1229_1230delTGinsCT p.Val410Ala | missense | N/A | Prot: ENSP00000434327.3 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 2 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
PhyloP100 | Uncertain | 7.1 |
Splicing Scores
No splicing scores have been computed for this variant.
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.